GGrantIndex
← Leaderboards

University Of Kentucky

Lexington, KY

Compare ↔
$2,868,842,532
Total funding
2,925
Grants

Funding over time

peak $191.3M · FY2005–25
$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,731,397,799 · 2803
CDC$94,237,612 · 48
FDA$30,018,145 · 15
USDA$8,440,548 · 9
AHRQ$2,729,051 · 15
NSF$1,435,236 · 30
DOE$559,151 · 2
ACF$24,990 · 1
SAMHSA$0 · 2

By mechanism

R01$1,490,934,263 · 947
P20$116,785,707 · 290
R21$114,080,539 · 302
P30$104,100,379 · 103
P01$90,583,336 · 85
UM1$81,731,115 · 1

Investigators at University Of Kentucky

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Robert Nathaniel Helsley$2,651,5041 gr2Svetla Stefanova Slavova$2,440,8651 gr3Jeffery C Talbert$2,440,8651 gr4Jordan Patrick Harp$2,063,6231 gr5Wang-Xia Wang$1,975,2551 gr6Zhiguo Li$1,749,7381 gr7John M O'Brien$1,505,5921 gr8Maj-Linda B Selenica$1,339,9301 gr

Emerging Leaders

6–10 yrs in

1Lance Allen Johnson$7,508,8824 gr2Todd Justen Kilbaugh$6,809,8344 gr3Ramon C. Sun$5,151,1315 gr4Saurabh Chattopadhyay$3,496,4083 gr5Zhishan Wang$3,428,4072 gr6Katy Patras$3,395,8514 gr7Scott M Gordon$3,323,0952 gr8Ashley Winn Seifert$3,225,3182 gr

All-Time

Most funded here, all years

1Michal J. Toborek$31,839,15416 gr2Bernard Mark Evers$24,846,13315 gr3Jayakrishna Ambati$21,465,83413 gr4Kurt Francis Hauser$21,045,85116 gr5Craig R Rush$20,687,00416 gr6Sharon L. Walsh$19,171,66511 gr7Ilhem Messaoudi$18,420,28013 gr8John M Littleton$16,914,54919 gr

Largest grants

Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)$27,502,167
UM1 · FY2021 · DA
Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)$25,249,958
UM1 · FY2020 · DA
Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)$20,388,990
UM1 · FY2019 · DA
Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)$8,590,000
UM1 · FY2022 · DA
University of Kentucky Center for Clinical and Translational Science Enterprise Data Center Expansion$7,548,058
C06 · FY2024 · OD
Core Rederivation and Barrier Renovation$6,428,471
G20 · FY2010 · RR
Healthy Kentucky Research Building Fit-up for Vascular Research$6,000,000
C06 · FY2019 · OD
Development and distribution of a certified reference cigarette suitable for rese$5,153,652
UC2 · FY2014 · FD
Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse$4,721,164
U01 · FY2022 · DA
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,222,772
P01 · FY2022 · AG
Kentucky Center for Clinical and Translational Science$4,198,128
UL1 · FY2019 · TR
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,150,513
P01 · FY2023 · AG
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$4,131,531
P01 · FY2024 · AG
Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias$3,958,139
P01 · FY2025 · AG
Appalachian Tobacco Regulatory Science Team (AppalTRuST)$3,923,160
U54 · FY2023 · DA
Appalachian Tobacco Regulatory Science Team (AppalTRuST)$3,866,213
U54 · FY2024 · DA
Appalachian Tobacco Regulatory Science Team (AppalTRuST)$3,843,883
U54 · FY2025 · DA
Translating SHIP1 genetics to generate a novel Alzheimer's pharmacologic agent$3,791,020
RF1 · FY2018 · AG
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT$3,685,000
C06 · FY2004 · RR
The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional Studies$3,672,000
UF1 · FY2023 · NS